News CRISPR Therapeutics plans Nasdaq launch CRISPR Therapeutics, the Swiss genome-editing company, has filed for a $90 million initial public offering.
News Biogen’s haemophilia spin-out Bioverativ to launch early 201... Coming antibody drugs and gene therapy could transform treatment
News New haemophilia drug Elocta approved in Europe Elocta, a new drug co-marketed by Sobi and Biogen, has been approved in the European Union.
News DNA testing can help right racial imbalance in breast cancer Study suggests routine genomic testing could correct well-established disparities in breast cancer survival rates between white and black women.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
